Clinical Trials Logo

Rheumatic clinical trials

View clinical trials related to Rheumatic.

Filter by:
  • None
  • Page 1

NCT ID: NCT05388344 Completed - Rheumatic Clinical Trials

LUMINA : Measure the Effectiveness of the Booklet Named "Comprendre Les Essais Cliniques"

LUMINA
Start date: October 15, 2021
Phase:
Study type: Observational

Various studies have shown that many patients do not understand all the information provided by the study investigator and by the information sheet before entering a clinical research protocol. Many materials has been developped in previous research, trying to improve patients' understanding. Nonetheless, their effectiveness remains uncertain. The "LUMINA" project aims to measure the effectiveness of the booklet named "Comprendre les essais cliniques" with patients included or not included in clinical trials within the Clinical Neurosciences - Rheumatology pole of the CHU de Nice. The design of this study is "before/after". A questionnaire was submitted to the patients before and after reading the booklet. That method is used in order to show if there was a difference between the score obtained from the questionnaire before and after reading. This difference could reflect an improvement in patients' comprehension and, by extension, the effectiveness of the support the team developed.

NCT ID: NCT02383680 Recruiting - Clinical trials for Dermatologic Disorders

Yellow Fever Vaccination Under Low Dose Methotrexate Therapy

MTX_YF
Start date: December 2014
Phase: N/A
Study type: Observational

Travelers (n = 30, 15 taking low-dose methotrexate (MTX), 15 healthy controls (HC), seeking travel advice in one of the following Swiss Travel Centers (Aarau, Basel, Bern, Geneva, Lausanne, Zurich) and who have an indication for yellow fever (YF) vaccination according to the Swiss Federal Office of Public Health's vaccination recommendations are invited to participate in this study. After signing the consent form (i) YF viremia and (ii) anti-YF antibody production in patients taking low-dose MTX and HC will be compared after YF vaccination. It will be analyzed whether the percentage of people with protective antibodies differs between the two groups and (iii) vaccine side effects will be compared between the groups.